Shortages of iohexol and iodixanol intravenous contrast media products have been reported after a GE Healthcare production facility in Shanghai experienced an unexpected, temporary shutdown last month during a COVID-19-related lockdown in the city. Though the preeminent supplier is back up and running, it may take until July to right the resulting shortage.
Accordingly, hospitals across the U.S. are on high alert, with many enacting conservation plans that involve difficult decisions about which patients to prioritize.
Source: Medpage Today